| PERIOD ENDING | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | 31-Jul-08 | | Total Revenue | 144,201 | 167,400 | 179,654 | 253,179 | | Cost of Revenue | 83,481 | 95,557 | 98,523 | 127,548 | | | Gross Profit | 60,720 | 71,843 | 81,131 | 125,631 | | | Operating Expenses | | Research Development | 49,482 | 46,700 | 47,142 | 47,809 | | Selling General and Administrative | 45,910 | 45,404 | 54,982 | 54,198 | | Non Recurring | 462,072 | 76 | 1,110 |
-
| | Others | 6,224 | 6,404 | 8,363 | 8,671 | | | | Total Operating Expenses | 563,688 | 98,584 | 111,597 |
-
| | | | Operating Income or Loss | (502,968) | (26,741) | (30,466) | 14,953 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 938 | 4,095 | 4,796 | 228 | | Earnings Before Interest And Taxes | (502,030) | (22,646) | (25,670) | 15,181 | | Interest Expense | 1,852 | 1,844 | 1,853 | 1,855 | | Income Before Tax | (503,882) | (24,490) | (27,523) | 13,326 | | Income Tax Expense | (672) | 341 | (2,127) | 1,603 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (503,210) | (24,831) | (25,396) | 11,723 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (503,210) | (24,831) | (25,396) | 11,723 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($503,210) | ($24,831) | ($25,396) | $11,723 |
|
0.45% Nasdaq 
0.20%
Income Statement
